The inhibition produced a negative effect, thus proving that expression of miR-146a-5p in EVs can upregulate IL-10, CD206, Arg-1, and TGF-β and decrease the expression of NOTCH1, IL-1β, and iNOS in patients diagnosed with SLE. The gene discussed is MRC1; the disease is systemic lupus erythematosus.